Meiji Yasuda Asset Management Co Ltd. Has $2.62 Million Stock Holdings in Mettler-Toledo International, Inc. $MTD

Meiji Yasuda Asset Management Co Ltd. lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 11.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,215 shares of the medical instruments supplier’s stock after buying an additional 228 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Mettler-Toledo International were worth $2,616,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. increased its position in Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock worth $3,003,485,000 after acquiring an additional 30,535 shares during the period. Alliancebernstein L.P. grew its position in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after purchasing an additional 126,147 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after purchasing an additional 25,272 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in shares of Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock worth $479,673,000 after purchasing an additional 43,082 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock valued at $456,018,000 after buying an additional 385,864 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,314.38 on Tuesday. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01. The stock has a market capitalization of $27.08 billion, a P/E ratio of 33.28, a price-to-earnings-growth ratio of 3.92 and a beta of 1.37. The stock has a fifty day moving average of $1,253.95 and a 200-day moving average of $1,185.45.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Analyst Ratings Changes

MTD has been the topic of a number of analyst reports. Robert W. Baird increased their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI reduced their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Barclays started coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target for the company. UBS Group raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and cut their price objective for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Finally, Citigroup increased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Moderate Buy” and an average price target of $1,311.11.

Insider Buying and Selling

In related news, insider Gerry Keller sold 165 shares of the stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider owned 94 shares of the company’s stock, valued at $123,012.16. This represents a 63.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock worth $2,371,208 in the last three months. 0.77% of the stock is owned by corporate insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.